vs
Side-by-side financial comparison of ACTELIS NETWORKS INC (ASNS) and Q32 Bio Inc. (QTTB). Click either name above to swap in a different company.
Q32 Bio Inc. is the larger business by last-quarter revenue ($1.9M vs $1.4M, roughly 1.4× ACTELIS NETWORKS INC). Q32 Bio Inc. runs the higher net margin — 2991.2% vs -184.5%, a 3175.7% gap on every dollar of revenue.
Actelis Networks Inc develops and manufactures high-performance broadband access networking solutions for telecom operators, enterprises and government entities. Its core products include Ethernet over copper systems delivering cost-effective high-speed connectivity over existing copper infrastructure, with key markets across North America, Europe and the Asia-Pacific.
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing targeted antibody-based immunotherapies for autoimmune disorders, inflammatory conditions and rare immunological diseases with unmet medical needs, operating primarily across North America and European markets.
ASNS vs QTTB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4M | $1.9M |
| Net Profit | $-2.5M | $57.7M |
| Gross Margin | 35.1% | — |
| Operating Margin | -122.3% | — |
| Net Margin | -184.5% | 2991.2% |
| Revenue YoY | 28.6% | — |
| Net Profit YoY | -40.1% | 506.9% |
| EPS (diluted) | $-5.08 | $4.70 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4M | $1.9M | ||
| Q3 25 | $643.0K | $-220.0K | ||
| Q2 25 | $941.0K | $-284.0K | ||
| Q1 25 | $721.0K | $-371.0K | ||
| Q4 24 | $1.1M | $0 | ||
| Q3 24 | $2.5M | $0 | ||
| Q2 24 | $3.4M | $0 | ||
| Q1 24 | $726.0K | $0 |
| Q4 25 | $-2.5M | $57.7M | ||
| Q3 25 | $-2.0M | $-7.4M | ||
| Q2 25 | $-1.9M | $-9.5M | ||
| Q1 25 | $-1.9M | $-11.0M | ||
| Q4 24 | $-1.8M | $-14.2M | ||
| Q3 24 | $-511.0K | $-17.6M | ||
| Q2 24 | $-78.0K | $-17.0M | ||
| Q1 24 | $-2.0M | $1.0M |
| Q4 25 | 35.1% | — | ||
| Q3 25 | 28.5% | — | ||
| Q2 25 | 32.4% | — | ||
| Q1 25 | 34.8% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 68.6% | — | ||
| Q2 24 | 56.6% | — | ||
| Q1 24 | 30.3% | — |
| Q4 25 | -122.3% | — | ||
| Q3 25 | -300.0% | 3444.1% | ||
| Q2 25 | -188.4% | 3229.2% | ||
| Q1 25 | -251.3% | 3296.0% | ||
| Q4 24 | -154.0% | — | ||
| Q3 24 | -12.5% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | -257.7% | — |
| Q4 25 | -184.5% | 2991.2% | ||
| Q3 25 | -307.9% | 3358.6% | ||
| Q2 25 | -202.0% | 3341.2% | ||
| Q1 25 | -258.0% | 2973.3% | ||
| Q4 24 | -169.4% | — | ||
| Q3 24 | -20.1% | — | ||
| Q2 24 | -2.3% | — | ||
| Q1 24 | -273.6% | — |
| Q4 25 | $-5.08 | $4.70 | ||
| Q3 25 | $-0.17 | $-0.60 | ||
| Q2 25 | $-0.21 | $-0.78 | ||
| Q1 25 | $-0.22 | $-0.90 | ||
| Q4 24 | $-7.90 | $2.63 | ||
| Q3 24 | $-0.09 | $-1.46 | ||
| Q2 24 | $-0.01 | $-1.42 | ||
| Q1 24 | $-0.50 | $-6.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $48.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.8M | $42.0M |
| Total Assets | $9.5M | $61.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $48.3M | ||
| Q3 25 | $1.5M | $49.0M | ||
| Q2 25 | $393.0K | $54.8M | ||
| Q1 25 | $1.1M | $65.5M | ||
| Q4 24 | $2.0M | $78.0M | ||
| Q3 24 | $2.2M | $89.1M | ||
| Q2 24 | $2.4M | $97.7M | ||
| Q1 24 | $1.4M | $115.5M |
| Q4 25 | — | — | ||
| Q3 25 | $150.0K | — | ||
| Q2 25 | $150.0K | — | ||
| Q1 25 | $150.0K | — | ||
| Q4 24 | $150.0K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $148.0K | — |
| Q4 25 | $4.8M | $42.0M | ||
| Q3 25 | $3.0M | $-18.4M | ||
| Q2 25 | $1.3M | $-12.2M | ||
| Q1 25 | $2.6M | $-4.0M | ||
| Q4 24 | $3.0M | $5.7M | ||
| Q3 24 | $3.1M | $18.3M | ||
| Q2 24 | $1.1M | $33.5M | ||
| Q1 24 | $-1.7M | $48.8M |
| Q4 25 | $9.5M | $61.8M | ||
| Q3 25 | $6.9M | $57.8M | ||
| Q2 25 | $6.0M | $66.1M | ||
| Q1 25 | $7.1M | $79.1M | ||
| Q4 24 | $8.2M | $92.3M | ||
| Q3 24 | $8.8M | $104.5M | ||
| Q2 24 | $8.4M | $124.2M | ||
| Q1 24 | $10.5M | $152.3M |
| Q4 25 | — | — | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.06× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.1M | $-6.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | -0.11× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.1M | $-6.2M | ||
| Q3 25 | $-2.4M | $-4.2M | ||
| Q2 25 | $-1.0M | $-10.7M | ||
| Q1 25 | $-2.2M | $-12.5M | ||
| Q4 24 | $-1.8M | $-11.4M | ||
| Q3 24 | $-2.4M | $-19.5M | ||
| Q2 24 | $-2.1M | $-22.2M | ||
| Q1 24 | $-203.0K | $-14.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-11.4M | ||
| Q3 24 | — | $-19.6M | ||
| Q2 24 | — | $-22.2M | ||
| Q1 24 | $-204.0K | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -28.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | -0.11× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -14.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASNS
| Europe Middle East And Africa | $1.1M | 83% |
| Other | $228.0K | 17% |
QTTB
Segment breakdown not available.
